Confidentiality of Interim Results in Cardiovascular (CV) Outcomes Safety Trials Part 15 Public Hearing: August 11, 2014

 
1. Please provide your name, affiliation, and contact information.
2. How do you plan to participate in this meeting?
3. Please indicate whether you wish to address any of the issues or make a presentation.
Please submit questions/presentations to indira.hills@fda.hhs.gov

Meeting Location: FDA White Oak Campus, Building 31, The Great Room (Room 1503), White Oak Campus Conference Center 10903 New Hampshire Avenue, Silver Spring, Maryland 20993. Contact Indira Hills at indira.hills@fda.hhs.gov
Powered by SurveyMonkey
Check out our sample surveys and create your own now!